AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring

计划入组 50 人 · 首次发布于 2025 年 10 月 7 日

Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis

计划入组 150 人 · 首次发布于 2012 年 12 月 31 日

Project Guard: Reducing Alcohol Misuse/Abuse in the National Guard

计划入组 850 人 · 首次发布于 2016 年 8 月 9 日

T-Guard

H-Guard

COVI-GUARD

LIGHT GUARD, LLC

United States

NATIONAL GUARD HEALTH AFFAIRS

Saudi Arabia

Guard Therapeutics International AB

Sweden

AccurKardia's AI-Powered Hyperkalemia Detection Software Receives FDA Breakthrough Device Designation

GUARD-AF Trial: iRhythm's Zio XT Patch Increases AF Detection in Primary Care

First Patient Dosed in Guard Therapeutics' Phase 2b Study POINTER